Shares of Dye & Durham Limited (TSE:DND – Get Free Report) have earned a consensus recommendation of “Moderate Buy” from the six brokerages that are presently covering the stock, MarketBeat Ratings reports. One research analyst has rated the stock with a hold rating and five have given a buy rating to the company. The average 12 month price objective among brokers that have updated their coverage on the stock in the last year is C$22.50.
A number of analysts recently issued reports on DND shares. Canaccord Genuity Group dropped their target price on shares of Dye & Durham from C$27.50 to C$23.00 in a research report on Friday, February 14th. Cormark lowered shares of Dye & Durham from a “moderate buy” rating to a “hold” rating in a research report on Friday, February 14th. Scotiabank reduced their target price on shares of Dye & Durham from C$25.00 to C$20.00 in a report on Friday, February 14th. CIBC lowered their price target on Dye & Durham from C$30.00 to C$25.00 in a report on Friday, February 14th. Finally, BMO Capital Markets cut their price objective on Dye & Durham from C$22.00 to C$20.00 in a research report on Friday, February 14th.
Dye & Durham Stock Performance
Insider Activity at Dye & Durham
In other Dye & Durham news, insider Plantro Ltd. acquired 89,400 shares of the stock in a transaction on Monday, February 24th. The stock was purchased at an average price of C$12.48 per share, for a total transaction of C$1,115,667.30. Company insiders own 25.60% of the company’s stock.
About Dye & Durham
Dye & Durham Ltd is engaged in providing cloud-based software and technology solutions designed to improve efficiency and increase productivity for legal and business professionals. The company has business operations in Canada and the United Kingdom. The customers include law firms, financial service institutions, and government organizations.
Read More
- Five stocks we like better than Dye & Durham
- What is a Special Dividend?
- D-Wave: Multiple Use Cases Emerge Following Quantum Supremacy
- What is the FTSE 100 index?
- Amazon Falls Back to a Key Support Line: Here’s How to Play It
- 3 Healthcare Dividend Stocks to Buy
- Buffett Trims Equities, But Still Keeps Buying This Stock
Receive News & Ratings for Dye & Durham Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dye & Durham and related companies with MarketBeat.com's FREE daily email newsletter.